Literature DB >> 16621990

Autoreactive T cells mediate NK cell degeneration in autoimmune disease.

Ruolan Liu1, Luc Van Kaer, Antonio La Cava, Mary Price, Denise I Campagnolo, Mary Collins, Deborah A Young, Timothy L Vollmer, Fu-Dong Shi.   

Abstract

Emerging evidence indicates that NK cells play an important and complex role in autoimmune disease. Humans with autoimmune diseases often have reduced NK cell numbers and compromised NK cell functions. Mechanisms underlying this NK cell degeneration and its biological significance are not known. In this study we show that, in an experimental model of human autoimmune myasthenia gravis induced by a self-Ag, the acetylcholine receptor, NK cells undergo proliferation during the initiation of autoimmunity, followed by significant degeneration associated with the establishment of the autoreactive T cell response. We show that NK cell degeneration was mediated by IL-21 derived from autoreactive CD4(+) T cells, and that acetylcholine receptor-immunized IL-21R-deficient mice, with competent NK cells, developed exacerbated autoimmunity. Thus, NK cell degeneration may serve as a means evolved by the immune system to control excessive autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621990     DOI: 10.4049/jimmunol.176.9.5247

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Alterations of natural killer cells in traumatic brain injury.

Authors:  Xiao-Dong Kong; Sheng Bai; Xin Chen; Hui-Jie Wei; Wei-Na Jin; Min-Shu Li; Yaping Yan; Fu-Dong Shi
Journal:  Neurosci Bull       Date:  2014-12-02       Impact factor: 5.203

Review 2.  Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy.

Authors:  Isabela Pedroza-Pacheco; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

3.  GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity.

Authors:  Mark D Bunting; Antiopi Varelias; Fernando Souza-Fonseca-Guimaraes; Iona S Schuster; Katie E Lineburg; Rachel D Kuns; Peter Fleming; Kelly R Locke; Nicholas D Huntington; Bruce R Blazar; Steven W Lane; Siok-Keen Tey; Kelli P A MacDonald; Mark J Smyth; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Blood       Date:  2016-12-07       Impact factor: 22.113

4.  Deletion of Fanca or Fancd2 dysregulates Treg in mice.

Authors:  Wei Du; Ozlem Erden; Andrew Wilson; Jared M Sipple; Jonathan Schick; Parinda Mehta; Kasiani C Myers; Kris A Steinbrecher; Stella M Davies; Qishen Pang
Journal:  Blood       Date:  2014-02-05       Impact factor: 22.113

5.  Natural killer cells in NOD.NK1.1 mice acquire cytolytic function during viral infection and provide protection against cytomegalovirus.

Authors:  Mark T Orr; Joshua N Beilke; Irina Proekt; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

Review 6.  Natural killer cells as indispensable players and therapeutic targets in autoimmunity.

Authors:  Fu-Dong Shi; Qinghua Zhou
Journal:  Autoimmunity       Date:  2010-08-11       Impact factor: 2.815

7.  Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.

Authors:  Dolores B Njoku; Zhaoxia Li; Nicole D Washington; Jenelle L Mellerson; Monica V Talor; Rajni Sharma; Noel R Rose
Journal:  Eur J Immunol       Date:  2009-06       Impact factor: 5.532

Review 8.  Cross-Disease Transcriptomics: Unique IL-17A Signaling in Psoriasis Lesions and an Autoimmune PBMC Signature.

Authors:  William R Swindell; Mrinal K Sarkar; Yun Liang; Xianying Xing; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2016-05-17       Impact factor: 8.551

9.  NK cells inhibit T-bet-deficient, autoreactive Th17 cells.

Authors:  W Wu; S Shi; H-G Ljunggren; A L Cava; L Van Kaer; F-D Shi; R Liu
Journal:  Scand J Immunol       Date:  2012-12       Impact factor: 3.487

10.  Elevated serum IL-21 levels in hantavirus-infected patients correlate with the severity of the disease.

Authors:  Hongmei Chen; Hongli Liu; Yuefei Wang; Yucong Yang; Yingren Zhao
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.